PREGABALIN LAPL pregabalin 20 mg/mL oral solution bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

pregabalin, Quantity: 20 mg/mL

Disponible des:

Lupin Australia Pty Limited

Designació comuna internacional (DCI):

Pregabalin

formulario farmacéutico:

Oral Liquid, solution

Composición:

Excipient Ingredients: sucralose; monobasic sodium phosphate monohydrate; purified water; dibasic sodium phosphate; propyl hydroxybenzoate; methyl hydroxybenzoate; Flavour

Vía de administración:

Oral

Unidades en paquete:

1

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Resumen del producto:

Visual Identification: A clear colorless liquid with characteristic banana odor.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 6 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-12-05